COVID-19 Update: Impact on Digital Pathology Market 2020

In current clinical
practices, digital
pathology technology has
been instrumental. In the background of the latest Coronavirus outbreak, it has
become more important resource in the research laboratory ecosystems and is
gaining traction recently. Although it was initially created as a
cost-effective pathological method to help pathologies achieve better
efficiency, digital pathology is now reemerging as a key item for pathologies
to present extended workflows in the global pandemic. Including emerging
technologies as artificial intelligence (AI) and machine learning, the
unprecedented advantages of digital pathology integration provide incredible
diagnostic possibilities far beyond traditional cardiology, and radiation. The
COVID-19 crisis immediately led to a rising demand for digital pathology, and
the pathology industry’s fate may forever be changed.

Download
FREE Sample Report: To Know the Impact of COVID-19 on this Industry@ https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impact-on-digital-pathology-in-the-healthcare-industry

Global
Digital Pathology Market

Global Digital
Pathology Market, By Type (Human Pathology, Veterinary Pathology), Product
(Scanners, Software, Communication Systems, Storage Systems), Application (Drug
Discovery, Disease Diagnosis, Teleconsultation, Training & Education), End
Users (Pharmaceutical & Biotechnology, Hospitals, Academic Research
Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France,
Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan,
China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia,
Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America,
South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East &
Africa) Industry Trends and Forecast to 2027.

Market
Analysis and Insights : Global Digital Pathology Market

Digital pathology market is expected to gain market growth in the forecast period of 2020
to 2027. Data Bridge Market Research analyses the market to account to USD
1,460.83 million by 2027 growing at a CAGR of 13.25% in the above-mentioned
forecast period. The rising prevalence of cancer diseases is going to help in
driving the growth of the digital pathology market.

The rising adoption
of digital pathology to enhance lab efficiency and growing applications of
digital pathology in drug development and companion diagnostics is likely to
accelerate the growth of the digital pathology market in the forecast period of
2020-2027. On the other hand, introduction of growing demand of personalized
medicine and affordable scanners for private pathology practices will further
boost various opportunities that will lead to the growth of the digital
pathology market in the above mentioned forecast period.

Global
Anatomic Pathology Market

Global Anatomic
Pathology Market By Product & Service (Instrument, Consumables, Antibodies,
Others), End User (Pathology Labs, Research Institutes, Hospitals, Others),
Application (Disease Diagnosis, Drug Discovery & Development, Other
Applications), Geography (North America, South America, Europe, Asia-Pacific,
Middle East and Africa) – Industry Trends & Forecast to 2026

Market
Analysis: Global Anatomic Pathology Market

Global Anatomic
Pathology Market is expected to rise from its initial estimated value of USD
18.66 billion in 2018 to an estimated value of USD 30.53 billion by 2026,
registering a CAGR of 6.35% in the forecast period of 2019-2026. This rise in
market value can be attributed to the increasing Incidence of Cancer.

COVID-19 creates a
great need for the remote working of pathologists which leads to a prolific
demand for digital pathologies. The future development of digital pathology
environments is further complemented by recent regulatory developments.

Market
Definition: Global Anatomic Pathology Market

Anatomic pathology
is a medical speciality that is required in the diagnosis of disease based on
the microscopic, macroscopic, biochemical, immunologic and molecular
examination of organs and tissues. In the last few years, surgical pathology
has evolved extremely, from an ancient examination of whole bodies (autopsy) to
modern techniques needed for the diagnosis and prognosis of cancer to guide
treatment decision-making in oncology.

Digital Pathology, which records high-resolution tissue specimen images, was essential
for the preservation of surgeries by pathologists during the pandemic. Such
visual images can be viewed whenever possible and are easily exchanged in
secondary opinions and views, or online, by overcoming the limitations of
working with glass dispositive and microscopes.

The growing need
for remote operations strongly drives this market for digital pathology.
Importantly, a key regulatory development is also being accelerated. The demand
for digital pathology has thus risen from both commercial and academic
laboratories. Health centers have adopted the technology to promote joint
training sessions and access to expertise. Many medical schools have already
migrated online and now deliver a similar, if not the same, experience as
students in the classroom.

 Market
Research Related Blogs 

·       
Global digital pathology market to witness high demand due to
rising cases of cancer worldwide